Previous close | 0.7000 |
Open | 0.7000 |
Bid | 0.6500 |
Ask | 0.8000 |
Strike | 22.50 |
Expiry date | 2024-08-16 |
Day's range | 0.7000 - 0.7000 |
Contract range | N/A |
Volume | |
Open interest | 36 |
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today released findings from its 2024 LGBTQ+ family building survey. The report, which surveyed over 1,100 LGBTQ+ individuals in the U.S. planning to build their families, highlights the unique challenges LGBTQ+ patients face, including struggles with insufficient access to care, financial constraints, and lack of mental health support throu
Kindbody, the leading national fertility clinic network and global family-building benefits provider for employers, today announced its Founder and Executive Chairman, Gina Bartasi, will return as the company's CEO during a time of unprecedented growth. The Company recently shared that it expected to deliver revenue in the range of $225-$250 million for 2024 and is now profitable after years of significant investment into new clinic locations and proprietary technology. Bartasi succeeds Annbeth
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024, at 9:00 A.M. Eastern Time. A live audiocast and replay will be available from the Events and Presentations section of Progyny’s website at http://investors.progyny